A Breath Fungal Secondary Metabolite Signature to Diagnose Invasive Aspergillosis
Sophia Koo(Dana-Farber Brigham Cancer Center), Francisco M. Marty(Brigham and Women's Hospital), Stephen D. Daniels(Brigham and Women's Hospital), Sean M. Fortier(University of Michigan), Lindsey R. Baden(Brigham and Women's Hospital), Preshious Rearden(Draper Laboratory), Horatio Thomas(Brigham and Women's Hospital), James C. Comolli(Draper Laboratory), Robert C. Lynch(Brigham and Women's Hospital), Margaret M. Shea(Brigham and Women's Hospital)
Cited by 150
Related Papers
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981